PRXL Share Price

Open 63.31 Change Price %
High 63.93 1 Day 0.57 0.91
Low 63.17 1 Week 2.24 3.66
Close 63.41 1 Month 1.06 1.70
Volume 381278 1 Year -4.16 -6.16
52 Week High 72.32
52 Week Low 51.16
PRXL Important Levels
Resistance 2 64.11
Resistance 1 63.82
Pivot 63.50
Support 1 63.00
Support 2 62.71
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
SIRI 5.13 1.18%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
CYTR 0.83 36.07%
SUSQ 14.20 -0.77%
More..
NASDAQ USA Top Gainers Stocks
SPIR 0.02 100.00%
CPSL 0.09 50.00%
LOCM 0.09 50.00%
RITT 0.03 50.00%
OPTT 2.74 49.73%
CYTR 0.83 36.07%
WRES 0.09 28.57%
BSDM 0.62 26.53%
ATRM 1.89 26.00%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

PAREXEL International Corporation (NASDAQ: PRXL)

PRXL Technical Analysis 3
As on 24th Apr 2017 PRXL Share Price closed @ 63.41 and we RECOMMEND Sell for LONG-TERM with Stoploss of 64.62 & Sell for SHORT-TERM with Stoploss of 63.62 we also expect STOCK to react on Following IMPORTANT LEVELS.
PRXL Target for April
1st Target up-side 65.94
2nd Target up-side 67.92
3rd Target up-side 69.9
1st Target down-side 60.28
2nd Target down-side 58.3
3rd Target down-side 56.32
PRXL Other Details
Segment EQ
Market Capital 1867869184.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.parexel.com
PRXL Address
PRXL
195 West Street
Waltham, MA 02451
United States
Phone: 781-487-9900
Fax: 781-487-0525
PRXL Latest News
Interactive Technical Analysis Chart PAREXEL International Corporation ( PRXL NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on PAREXEL International Corporation
PRXL Business Profile
PAREXEL International Corporation (PAREXEL) is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. It operates it three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS) and Perceptive Informatics, Inc. (Perceptive). The Company�s product and service offerings include clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics / outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, post-marketing surveillance. In May 2013, PAREXEL International Corp acquired the entire share capital of HERON Group Ltd.